Moleculin Biotech Inc. (MBRX) Fundamentals

Moleculin Biotech Inc is a clinical-stage pharmaceutical company with a focus on the treatment of highly resistant cancers and viruses through the development of its drug candidates. The company has three core technologies: Annamycin which is a next-generation anthracycline; Immune/Transcription Modulators, of which WP1066 is a member; and Metabolism/Glycosylation Inhibitors, of which WP1122 is a member.
SHARE INFORMATION
Market Cap$ 36,071,062
Shares Outstanding28,627,827
Float28,011,986
Percent Float97.85%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -0.59
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions52
Institutional Holdings Date2022-12-31
Institutional Bought Previous 3 Months14,696
Institutional Holdings Percent20.3%
Institutional Sold Previous 3 Months17,706
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months67,500
Insider Holdings Percent3.1
Insider Sold Previous 3 Months-
Insider Shares Owned891,648
TRADING INFO
52 Week High$ 2.05
52 Week Low$ 0.82
52 Week High Change$ -17.11
21 Day Moving Average$ 1.2099
21 Day Extended Moving Average$ 1.2466
50 Day Moving Average$ 1.2416
50 Day Extended Moving Average$ 1.2278
200 Day Moving Average$ 1.3815
200 Day Extended Moving Average$ 1.4364
10 Day Average Volume48,532
20 Day Average Volume67,804
30 Day Average Volume113,848
50 Day Average Volume110,178
Alpha-0.035079
Beta1.9443
Standard Deviation0.203997
R20.264142
7 Day Price Change$ -0.03
7 Day Percent Change-2.33%
21 Day Price Change$ 0.10
21 Day Percent Change8.62%
30 Day Price Change$ 0.05
30 Day Percent Change4.13%
Month to Date Price Change$ 0.20
Month to Date Percent Change18.87%
Quarter to Date Price Change$ 0.20
Quarter to Date Percent Change18.87%
180 Day Price Change$ -0.45
180 Day Percent Change-26.32%
200 Day Price Change$ -0.43
200 Day Percent Change-25.44%
Year to Date Price Change$ 0.20
Year to Date Percent Change18.87%

Moleculin Biotech Inc. (MBRX) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.60
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio8.40
Leverage Ratio1.10
Quick Ratio7.90
Long Term Debt To Capital0.01
VALUATION MEASURES
PE Ratio-1.50
Enterprise Value$ -12,985,104
Price to Sales0.00
Price to Free Cash-1.80
PE High Last 5 Years-5.10
Price To Book0.60
Price To Cash Flow0.00
PE Low Last 5 Years-2.10
Price to Tangible Book0.60
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-35.70
Return on Equity-39.42
Return on Capital-35.74

Moleculin Biotech Inc. (MBRX) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorGrant Thornton LLP
CEOWalter V. Klemp
Emplyoees21
Last AuditUQ
CIK0001659617
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address5300 Memorial Drive
Suite 950
Houston, TX 77007
Websitehttps://www.moleculin.com
Facsimile+1 817 394-2127
Telephone+1 713 300-5160
Emailmbrx@lythampartners.com


Your Recent History
NASDAQ
MBRX
Moleculin ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.